Good
Mostly Aligned
Patient Risk:
Moderate
Summary
For the abuse/misuse/addiction risk portion, the response aligns with the label’s boxed warning and Abuse/Misuse/Dependence sections. However, several other listed statements (e.g., generic/brand inactive ingredient differences, legality/penalties, and specific monitoring/assessments) are not evaluated here against label text and therefore may be unsupported relative to the supplied prescribing information excerpt.
Category Scores
Accurate Statements
Adderall has a high potential for abuse and misuse that can lead to the development of a substance use disorder, including addiction, and misuse/abuse can result in overdose and death.
Boxed Warning (WARNING: ABUSE, MISUSE, AND ADDICTION) and WARNINGS—Abuse, Misuse, and Addiction; also reiterated in DRUG ABUSE AND DEPENDENCE—Controlled Substance; Abuse; Dependence.
Unsupported Statements
Adderall is a brand-name medication manufactured by Takeda Pharmaceuticals.
Not supported by the provided label excerpts.
Generic Adderall contains the same active pharmaceutical ingredients as brand-name Adderall: dextroamphetamine and amphetamine.
Not supported by the provided label excerpts.
Generic Adderall contains dextroamphetamine and amphetamine in the same dosage as the brand-name version.
Not supported by the provided label excerpts.
The FDA requires generic drugs to be bioequivalent to their brand-name counterparts.
Not supported by the provided label excerpts.
Generic drugs are expected to have the same therapeutic effect as brand-name counterparts.
Not supported by the provided label excerpts.
The primary differences between generic and brand-name Adderall are typically in inactive ingredients such as fillers and binders.
Not supported by the provided label excerpts.
Inactive ingredients can affect the appearance of the pill.
Not supported by the provided label excerpts.
Generic Adderall differs from brand-name Adderall in manufacturer.
Not supported by the provided label excerpts.
Possessing or selling Adderall without a prescription is a federal offense in the United States.
Not supported by the provided label excerpts.
The severity of penalties for possessing or selling Adderall without a prescription depends on factors such as quantity of the drug, prior offenses, and whether the individual is involved in distribution or trafficking.
Not supported by the provided label excerpts.
Penalties for possessing or selling Adderall without a prescription can include substantial fines.
Not supported by the provided label excerpts.
Penalties for possessing or selling Adderall without a prescription can include lengthy prison sentences.
Not supported by the provided label excerpts.
Penalties for possessing or selling Adderall without a prescription can result in a criminal record.
Not supported by the provided label excerpts.
A criminal record can impact future employment and educational opportunities.
Not supported by the provided label excerpts.
Misusing Adderall can lead to cardiovascular problems including increased heart rate.
While the label includes increased heart rate/blood pressure in the context of abuse/misuse, this specific statement appears as a general claim list and is not directly tied to the provided claim evaluation; treated as unsupported for this audit because the prompt did not provide the full mapping to the excerpted label sections for each subclaim.
Misusing Adderall can lead to cardiovascular problems including increased blood pressure.
Same reason as above (treated as unsupported for this audit’s per-item verification based on provided excerpts).
Misusing Adderall can cause psychological effects including anxiety.
Same reason as above (treated as unsupported for this audit’s per-item verification based on provided excerpts).
Misusing Adderall can cause psychological effects including paranoia.
Same reason as above (treated as unsupported for this audit’s per-item verification based on provided excerpts).
Misusing Adderall can cause psychological effects including psychosis.
Same reason as above (treated as unsupported for this audit’s per-item verification based on provided excerpts).
Long-term misuse of Adderall can result in dependence.
Label supports physical dependence and withdrawal after prolonged use, but the phrasing 'long-term misuse ... dependence' is not an exact label statement in the provided excerpt.
Long-term misuse of Adderall can result in withdrawal symptoms when the drug is stopped.
Label supports withdrawal signs/symptoms after abrupt discontinuation following prolonged use of CNS stimulants including Adderall; the wording is close but not exact and is treated as partially unsupported due to 'long-term misuse' framing rather than label framing ('prolonged use' of CNS stimulants).
Contradictions
Important Omissions
No attempt to quote or cite the label sections specifically for the non-abuse-related legal, generic substitution, manufacturer, and detailed adverse effect subtype claims; these were included as separate assertions without label-based support in the provided excerpt.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Abuse/misuse/addiction risk language is consistent with the label excerpt. However, numerous additional statements (especially legal/generic/manufacturer claims and specific symptom lists) are not supported by the provided label text excerpt, reducing overall label alignment quality.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Mostly Aligned
Primary Issue
Only a subset of the listed statements is directly supported by the provided label excerpts; many additional claims are not substantiated by the supplied prescribing information.
Suggested Improvement
Limit claims to what is explicitly supported by the provided label sections (Boxed Warning/WARNINGS/DRUG ABUSE AND DEPENDENCE) and remove or label as 'not stated in the provided prescribing information' any legal, generic/manufacturer, or detailed symptom/penalty statements that are not directly evidenced in the excerpt.